MarketInOut Stock Screener Log In | Sign Up
 

Supernus Pharmaceuticals Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/23/2026 16:00
Supernus Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,390.1 mln
Float54.53 mln
Earnings Date10/29/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.59
Likely reliable

Relative Strength

37 / 100
Underperforming

Debt / Equity

0.04
Debt-free

Pre-Tax Margin

-15%
Loss-making

ROE

-10.40
Negative

Business Description

Supernus Pharmaceuticals is a US-based company focused on developing and selling medicines that treat brain and nervous system conditions. Its current lineup includes treatments for ADHD, Parkinson's disease, epilepsy, cervical dystonia, and chronic sialorrhea, sold through wholesalers, specialty pharmacies, and distributors. The company also has several drugs in clinical trials targeting epilepsy, treatment-resistant depression, and ADHD. Founded in 2005 and headquartered in Rockville, Maryland, Supernus continues to grow its portfolio through internal research and external development partnerships.

Key Fundamentals

EPS-1.92
ROE-10.40
RPS14.47
ROIC-6.55
ROA-7.48
Interest Cover-48.30
EBITDA, mln-19.43
EV / EBITDA-113
EV / EBIT-18.06
Revenue, mln830
EV / Revenue2.63

Quote Details

Last 40.70
Change -1.37 (-3.26%)
Open 41.68
Volume 1,159,336
Turnover 47,184,976
Average Volume 850,797

Financial Ratios

Pre-Tax Profit Margin-15
Leverage Ratio1.38
Current Ratio2.08
Price / Book2.45
Price / Tangible Book5.70
Price / Cash Flow120
Price / Free Cash Flow141
Debt / Equity0.04
Price / Sales2.97

Financial Strength

Altman Z-Score4.94
Piotroski F-Score 3 / 9
Beneish M-Score-2.59
Price to Intrinsic Value1.26
Shiller PE Ratio30.96
Short Ratio7.89
Short % of Float10.49

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 7.44% 92 / 100   
1 Month -5.98% 37 / 100   
2 Months -14.17% 27 / 100   
6 Months -18.21% 27 / 100   
1 Year -19.68% 30 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog